12-2020: Just released today from Italy, not-free good news for Actemra for treating 20 of 33 COVID-19 patients https://t.co/v8POqA96yG https://t.co/KJM4rX9Zi9 https://t.co/Xkqx9gk8wL https://t.co/4sQ9HqUtjO https://t.co/QDxT5893Mj https://t.co/OPfQWQi2Y8
10-23-2020: Just released today from Italy, COVID-19, Actemra: https://t.co/I8yzQSwgv7 https://t.co/rek0JN2UiB https://t.co/OHgGrMXCRZ https://t.co/2oi57ODgaP https://t.co/v8POqA96yG https://t.co/KJM4rX9Zi9 https://t.co/Xkqx9gk8wL https://t.co/4sQ9HqUtjO
11-24-2020: "The majority of patients in our study who switched from intravenous to subcutaneous Actemra preferred to return to the intravenous because of worsening of their symptoms" https://t.co/Xkqx9gk8wL https://t.co/2xRXcDuAc6 https://t.co/2oi57ODgaP
10-5-2020: The Italians have already completed 12 clinical trials that tested Actemra so why start another one? https://t.co/2oi57ODgaP https://t.co/v8POqA96yG https://t.co/KJM4rX9Zi9 https://t.co/Xkqx9gk8wL https://t.co/YTEdZAWZq2 https://t.co/GEQ9hSq1Vy
9-28-2020: In a clinical trial just released today from Brooklyn, New York, 65 patients received intravenous Actemra, 60 patients received subcutaneous Actemra, and zero patients received the fake Actemra: https://t.co/30zB2ppPvO https://t.co/Xkqx9gk8wL h
9-28-2020: In a clinical trial just released today from Brooklyn, New York, 65 patients received intravenous Actemra, 60 patients received subcutaneous Actemra, & zero patients received the fake Actemra: https://t.co/30zB2ppPvO https://t.co/Xkqx9gk8wL
9-29-2020: In a clinical trial just released today from Reggio Emilia, Italy, good news for Actemra (tocilizumab) for reducing the death rate of COVID-19 patients.☣☣Thank the 38 patients who were injected with the☠fake Actemra☠ https://t.co/Xkqx9gk8wL htt
1,289/ Italy (adult smoking rate was 23.7% in 2016) Of 79 with severe COVID-19 pneumonia and worsening acute respiratory failure, 3 were current smokers (3.8%) & 22 were former smokers (27.8%) https://t.co/EYGaUeA2vR